The implementation of Bill S2326 is significant as it paves the way for insurance policies in the state to cover neurofeedback therapy, which is a non-invasive technique aimed at enhancing mental health. This change stands to benefit young individuals who may be experiencing mental health issues and veterans grappling with the effects of PTSD. By requiring insurance providers to include this coverage, the bill aims to lessen the financial barriers that often prevent individuals from accessing necessary mental health treatments.
Summary
Bill S2326, introduced during the January session of 2022, advocates for the establishment of a pilot program specifically for neurofeedback therapy. This bill mandates insurance coverage for neurofeedback therapy for specific demographics: individuals up to the age of twenty-one, and military members or veterans diagnosed with post-traumatic stress disorder (PTSD), providing coverage for up to twenty sessions. The program is designed to run for two years, concluding on January 1, 2025. This initiative aims to address mental health needs in vulnerable populations, ensuring they have access to alternative therapeutic options.
Contention
While the bill seeks to provide essential support for mental health treatment, potential points of contention may arise concerning the efficacy and acceptance of neurofeedback therapy within the broader medical community. Critics might question the science backing neurofeedback, discussing whether it should be considered a standard treatment. Additionally, the limitation of twenty sessions raises concerns about whether this is sufficient for effective treatment, ultimately prompting discussions on the sustainability and long-term integration of neurofeedback therapy within the existing mental health framework.
Provides for the licensing and regulation of the practice of neurofeedback therapy; defines practice of neurofeedback therapy; establishes state board of neurofeedback therapy and the requirements to qualify for a license as a neurofeedback therapist.
Provides for the licensing and regulation of the practice of neurofeedback therapy; defines practice of neurofeedback therapy; establishes state board of neurofeedback therapy and the requirements to qualify for a license as a neurofeedback therapist.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Insurance: health insurers; coverage for medically necessary treatment related to or as a result of an acquired brain injury; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406cc.